TD Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
AC
SCM
TD Asset Management's BLUE Position: Q2 2021 in Review
TD Asset Management sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 2,056 shares — an estimated $803K sold.
TD Asset Management first reported a position in BLUE in Q3 2014 and held it in 27 quarters. The position peaked at $8.06M in Q1 2018. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.
- TD Asset Management reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
- TD Asset Management sold 2,056 bluebird bio shares in Q2 2021, an estimated $803K.
- TD Asset Management first reported a position in bluebird bio in Q3 2014 and held it in 27 quarters.
- TD Asset Management's bluebird bio position peaked at $8.06M in Q1 2018.
- 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.
Based on TD Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.